1515 — China Resources Medical Holdings Cashflow Statement
0.000.00%
- HK$3.75bn
- HK$5.18bn
- CNY9.18bn
Annual cashflow statement for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 270 | 423 | 493 | 839 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 216 | 153 | 493 | 11.7 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 40.7 | -198 | -401 | -199 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 710 | 864 | 1,195 | 1,270 | — |
| Capital Expenditures | -227 | -466 | -487 | -564 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,709 | -27.7 | -2,135 | 19 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,936 | -494 | -2,622 | -545 | — |
| Financing Cash Flow Items | -29.7 | -57.7 | -129 | -81.3 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 846 | -224 | -437 | -985 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -377 | 149 | -1,864 | -259 | — |